Physician profile
Pankaj K Bhatnagar
NPI 1417929175
$9,511.62
in general payments reported to CMS, 2019-2025
31 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,364 · 2020: $665 · 2021: $447 · 2022: $533 · 2023: $745 · 2024: $2,525 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Travel and Lodging: $1,657 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.23 |
| Travel and Lodging | $1,657.07 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,265.75 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $294.11 | 2020-2025 | Phasix Mesh |
| Acera Surgical, INC. | $254.18 | 2020-2024 | Restrata Wound Matrix |
| Organogenesis INC. | $251.43 | 2021-2025 | Puraply, Puraply Wound Matrix |
| Tela Bio, INC. | $215.01 | 2019-2021 | |
| Medtronic, INC. | $188.56 | 2022-2023 | Signia |
| Kerecis Limited | $159.39 | 2022 | |
| Travere Therapeutics, INC. | $139.93 | 2025 | Filspari |
| Ethicon US, LLC | $132.82 | 2019-2025 | Echelon Flex, Prolene |
| Kowa Pharmaceuticals America, INC. | $80.20 | 2022-2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $65.88 | 2021-2022 | |
| Bsn Medical INC | $51.40 | 2019 | |
| Biom'Up France Sas | $48.54 | 2020 | |
| Lemaitre Vascular, INC. | $40.86 | 2019-2024 | Artegraft Vascular Graft |
| Olympus America INC. | $28.75 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $27.19 | 2024 | Hemoblast Bellows |
| Covidien LP | $23.77 | 2019 | |
| Misonix INC | $22.87 | 2020 | |
| Abbott Laboratories | $21.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.94 | 2021 | |
| Kci USA, INC. | $20.69 | 2023 | Prevena |
| Conmed Corporation | $19.81 | 2022 | |
| Merck Sharp & Dohme LLC | $19.41 | 2019 | |
| Apollo Endosurgery US INC | $18.91 | 2022 | |
| Northgate Technologies, INC. | $16.38 | 2023 | Smoke Removel - Nebulae |
| Monaghan Medical Corporation | $16.37 | 2023 | Aeroeclipse |
| Cook Medical LLC | $15.07 | 2019 | |
| Integra Lifesciences Corporation | $14.89 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Medtronic USA, INC. | $14.04 | 2019 | |
| Boston Scientific Corporation | $11.77 | 2020 | |
| Teleflex LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Bhatnagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.